Clinical Trial

Media Orientation to Improve Childhood Vaccine Uptake and Address Parent and Caregivers Vaccine-related Anxiety: A Pilot Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Vaccine hesitancy-defined as delayed acceptance or refusal of vaccines despite availability-remains a significant barrier to childhood immunisation uptake in Nigeria, a country with high zero-dose unvaccinated children. Several factors limit vaccine uptake, including poor awareness, misinformation, fear, anxiety and a perceived sense of conspiracy. Yet, a gap exists to address this urgent problem. The proposed study seeks to pilot the feasibility and acceptability of a novel co-produced media campaign intervention called ASSURed awareness campaign to encourage childhood vaccine uptakE (ASSURE) with parent-caregivers who are not or partially up to date with their child's vaccination. The ASSURE intervention is designed to encourage vaccine uptake and access, reduce vaccine hesitancy whilst addressing vaccine-related anxiety. The ASSURE intervention is low-intensity, lasting approximately 3-5-minute designed to raise awareness of the need for vaccination uptake and its implications for children, including their development and well-being whist addressing vaccine related anxiety and fears. The proposed study is also to pilot and test the instrument to determine effectiveness and cost effectiveness including the mechanism on why the intervention might potentially work.
Trial Details
NCT Number NCT07510230
Lead Sponsor Teesside University
Collaborators: Jos University Teaching Hospital, University of Manchester
Conditions Anxiety, Vaccination Hesitancy, Vaccination Promotion, Vaccine Decision Making, Immunisation Anxiety Related Reaction
Enrollment 74 participants
Start Date 2026-04-20
Primary Completion 2027-02-08 (estimated)
Study Completion 2027-02-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-03